Atai Life Sciences Nv revenue was $308.00k for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was -$5.0k, down 112.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ATAI annual revenue was $308.0k, with -1.9% growth year-over-year.
ATAI past revenue growth
How has ATAI's revenue growth performed historically?
On Invalid Date, Atai Life Sciences Nv (NASDAQ: ATAI) reported Q4 2024 revenue of -$5.00 thousand up 127.78% year over year. In the same quarter last year, Atai Life Sciences Nv's revenue was $18.00 thousand.
What was Atai Life Sciences Nv's revenue in 2024?
Atai Life Sciences Nv's annual revenue for the twelve months ending Dec 31, 2024 was $308.00 thousand, a 1.91% decrease year over year.
How much does Atai Life Sciences Nv make in a day?
Based on Atai Life Sciences Nv annual revenue for the past five years, ATAI makes an average of $11,633.42 per day.
What was Atai Life Sciences Nv's annual revenue growth in the past year?
As of Q2 2025, Atai Life Sciences Nv's revenue has grown -1.91% year over year. This is 439.22 percentage points lower than the US Biotechnology industry revenue growth rate of 437.31%. Atai Life Sciences Nv's revenue in the past year totaled $308.00 thousand.
How much does Atai Life Sciences Nv make in a year?
Atai Life Sciences Nv's revenue by year for the past five years is:
Atai Life Sciences Nv's revenue for the twelve months ending Dec 31, 2024 was $308.00 thousand, a 1.91% decrease year over year.
Atai Life Sciences Nv's annual revenue for Dec 31, 2023 was $314.00 thousand, a 34.76% increase from 2022.
Atai Life Sciences Nv's annual revenue for 2022 was $233.00 thousand, a 98.86% decrease from 2021.
Atai Life Sciences Nv's annual revenue for 2021 was $20.38 million, a Infinity% increase from 2020.
Atai Life Sciences Nv's annual revenue for 2020 was $0.00, a N/A decrease from 2019.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.